丁酰胆碱酯酶
胆碱能的
内分泌学
内科学
肝细胞
纤维化
肝星状细胞
乙酰胆碱
免疫染色
化学
生物
胆碱酯酶
生长因子
毒蕈碱乙酰胆碱受体
自分泌信号
免疫组织化学
毒蕈碱乙酰胆碱受体M3
细胞生长
细胞生物学
基因表达
信号转导
转化生长因子
肝细胞生长因子
转化生长因子β
旁分泌信号
作者
Le Tao,Nuoya Liu,Wei Zhang,Zongguo Yang,Wenya Xing,Liu Wu,Linqi Hou,魏娉婷,Yuanyuan Xie,Wei Han,Yunqi Liu,Yesen Jin,Lianlian Xiang,Xuling Liu,Wenting Ma,Pingping Hu,Wei Li,Wenjun Zhou,Sai Wang,Hongzhuan Chen
出处
期刊:Gut
[BMJ]
日期:2026-09-23
卷期号:: gutjnl-2026
标识
DOI:10.1136/gutjnl-2026-338932
摘要
Background Butyrylcholinesterase (BuChE) is a metabolic enzyme implicated in Alzheimer’s disease, detoxification and depression. Although reduced BuChE expression is recognised in cirrhosis, its functional role in fibrogenesis remains undefined. Objective We investigated whether BuChE regulates fibrosis by modulating acetylcholine (ACh) bioavailability and identified downstream cholinergic signalling. Design BuChE expression was assessed via qPCR and immunostaining in patient biopsies. Its contribution was studied using Buche ΔHep , Buche KI/KI-Hep mice, pharmacological inhibition, mutant BuChE conditioned medium and recombinant protein. ACh release and muscarinic ACh receptor (ChRM) function were measured using patch-clamp and calcium mobilisation assay; ChRM3 role was tested via Chrm3 ΔHSC mice and AAV6-mediated overexpression. Results BUCHE mRNA and serum activity are significantly downregulated in fibrotic patients and mice, correlating negatively with F stage and alpha-smooth muscle actin expression. BuChE is predominantly expressed in hepatocytes in the liver, which can be reduced by transforming growth factor beta or platelet-derived growth factor treatment, and its anti-fibrotic function requires enzymatic activity. Hepatocyte BuChE deletion or inhibition increases hepatic stellate cell (HSC) activation and fibrosis across multiple models, whereas overexpression is protective, establishing causality. Loss of BuChE leads to accumulation of unmetabolised ACh, which activates HSCs as a damage associated molecular pattern signal via ChRM3-NF-κB signalling. Chrm3 ΔHSC mice exhibit attenuated HSC activation and fibrosis, whereas Chrm3 overexpression promotes fibrogenesis. Conclusion Hepatocyte injury disrupts BuChE activity, causing local ACh accumulation and subsequent HSC activation via ChRM3 signalling. This newly identified cholinergic circuit drives fibrosis and represents a druggable target for therapeutic intervention.
科研通智能强力驱动
Strongly Powered by AbleSci AI